IP5 SUBSTITUTED COMPOUNDS
The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-Z chains in positions R1, R2, R4, and R5. Also provided ar...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PERELLÓ BESTARD, Joan SALCEDO ROCA, Carolina PÉREZ FERRER, María del Mar CATENA RUIZ, Juan Lorenzo BASSISSI, Mohamad Firas SERRA COMAS, Carme LLEBARIA SOLDEVILA, Amadeu FERRER REYNÉS, Miquel David |
description | The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-Z chains in positions R1, R2, R4, and R5. Also provided are methods, pharmaceutical compositions and formulations, methods of use, articles of manufacture, and kits for the treatment of diseases and conditions such as pathological crystallization-related diseases and conditions.
La présente invention concerne des composés substitués par IP5 de formule générale I, leurs procédés de synthèse et leurs utilisations. Les composés substitués par IP5 de l'invention sont caractérisés pour avoir des chaînes -O(alkyl)nX, et-O(alkyl)yCy(alkyl)y'-Z dans les positions R1, R2, R4 et R5. L'invention concerne également des procédés, des compositions pharmaceutiques et des formulations, des procédés d'utilisation, des articles manufacturés et des kits pour le traitement de maladies et d'états tels que des maladies et des états pathologiques liés à la cristallisation pathologique. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024023360A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024023360A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024023360A13</originalsourceid><addsrcrecordid>eNrjZJD0DDBVCA51Cg7xDAkNcXVRcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgZGxsZmBo6GxsSpAgCinCEC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IP5 SUBSTITUTED COMPOUNDS</title><source>esp@cenet</source><creator>PERELLÓ BESTARD, Joan ; SALCEDO ROCA, Carolina ; PÉREZ FERRER, María del Mar ; CATENA RUIZ, Juan Lorenzo ; BASSISSI, Mohamad Firas ; SERRA COMAS, Carme ; LLEBARIA SOLDEVILA, Amadeu ; FERRER REYNÉS, Miquel David</creator><creatorcontrib>PERELLÓ BESTARD, Joan ; SALCEDO ROCA, Carolina ; PÉREZ FERRER, María del Mar ; CATENA RUIZ, Juan Lorenzo ; BASSISSI, Mohamad Firas ; SERRA COMAS, Carme ; LLEBARIA SOLDEVILA, Amadeu ; FERRER REYNÉS, Miquel David</creatorcontrib><description>The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-Z chains in positions R1, R2, R4, and R5. Also provided are methods, pharmaceutical compositions and formulations, methods of use, articles of manufacture, and kits for the treatment of diseases and conditions such as pathological crystallization-related diseases and conditions.
La présente invention concerne des composés substitués par IP5 de formule générale I, leurs procédés de synthèse et leurs utilisations. Les composés substitués par IP5 de l'invention sont caractérisés pour avoir des chaînes -O(alkyl)nX, et-O(alkyl)yCy(alkyl)y'-Z dans les positions R1, R2, R4 et R5. L'invention concerne également des procédés, des compositions pharmaceutiques et des formulations, des procédés d'utilisation, des articles manufacturés et des kits pour le traitement de maladies et d'états tels que des maladies et des états pathologiques liés à la cristallisation pathologique.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240201&DB=EPODOC&CC=WO&NR=2024023360A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240201&DB=EPODOC&CC=WO&NR=2024023360A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PERELLÓ BESTARD, Joan</creatorcontrib><creatorcontrib>SALCEDO ROCA, Carolina</creatorcontrib><creatorcontrib>PÉREZ FERRER, María del Mar</creatorcontrib><creatorcontrib>CATENA RUIZ, Juan Lorenzo</creatorcontrib><creatorcontrib>BASSISSI, Mohamad Firas</creatorcontrib><creatorcontrib>SERRA COMAS, Carme</creatorcontrib><creatorcontrib>LLEBARIA SOLDEVILA, Amadeu</creatorcontrib><creatorcontrib>FERRER REYNÉS, Miquel David</creatorcontrib><title>IP5 SUBSTITUTED COMPOUNDS</title><description>The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-Z chains in positions R1, R2, R4, and R5. Also provided are methods, pharmaceutical compositions and formulations, methods of use, articles of manufacture, and kits for the treatment of diseases and conditions such as pathological crystallization-related diseases and conditions.
La présente invention concerne des composés substitués par IP5 de formule générale I, leurs procédés de synthèse et leurs utilisations. Les composés substitués par IP5 de l'invention sont caractérisés pour avoir des chaînes -O(alkyl)nX, et-O(alkyl)yCy(alkyl)y'-Z dans les positions R1, R2, R4 et R5. L'invention concerne également des procédés, des compositions pharmaceutiques et des formulations, des procédés d'utilisation, des articles manufacturés et des kits pour le traitement de maladies et d'états tels que des maladies et des états pathologiques liés à la cristallisation pathologique.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD0DDBVCA51Cg7xDAkNcXVRcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgZGxsZmBo6GxsSpAgCinCEC</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>PERELLÓ BESTARD, Joan</creator><creator>SALCEDO ROCA, Carolina</creator><creator>PÉREZ FERRER, María del Mar</creator><creator>CATENA RUIZ, Juan Lorenzo</creator><creator>BASSISSI, Mohamad Firas</creator><creator>SERRA COMAS, Carme</creator><creator>LLEBARIA SOLDEVILA, Amadeu</creator><creator>FERRER REYNÉS, Miquel David</creator><scope>EVB</scope></search><sort><creationdate>20240201</creationdate><title>IP5 SUBSTITUTED COMPOUNDS</title><author>PERELLÓ BESTARD, Joan ; SALCEDO ROCA, Carolina ; PÉREZ FERRER, María del Mar ; CATENA RUIZ, Juan Lorenzo ; BASSISSI, Mohamad Firas ; SERRA COMAS, Carme ; LLEBARIA SOLDEVILA, Amadeu ; FERRER REYNÉS, Miquel David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024023360A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PERELLÓ BESTARD, Joan</creatorcontrib><creatorcontrib>SALCEDO ROCA, Carolina</creatorcontrib><creatorcontrib>PÉREZ FERRER, María del Mar</creatorcontrib><creatorcontrib>CATENA RUIZ, Juan Lorenzo</creatorcontrib><creatorcontrib>BASSISSI, Mohamad Firas</creatorcontrib><creatorcontrib>SERRA COMAS, Carme</creatorcontrib><creatorcontrib>LLEBARIA SOLDEVILA, Amadeu</creatorcontrib><creatorcontrib>FERRER REYNÉS, Miquel David</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PERELLÓ BESTARD, Joan</au><au>SALCEDO ROCA, Carolina</au><au>PÉREZ FERRER, María del Mar</au><au>CATENA RUIZ, Juan Lorenzo</au><au>BASSISSI, Mohamad Firas</au><au>SERRA COMAS, Carme</au><au>LLEBARIA SOLDEVILA, Amadeu</au><au>FERRER REYNÉS, Miquel David</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IP5 SUBSTITUTED COMPOUNDS</title><date>2024-02-01</date><risdate>2024</risdate><abstract>The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-Z chains in positions R1, R2, R4, and R5. Also provided are methods, pharmaceutical compositions and formulations, methods of use, articles of manufacture, and kits for the treatment of diseases and conditions such as pathological crystallization-related diseases and conditions.
La présente invention concerne des composés substitués par IP5 de formule générale I, leurs procédés de synthèse et leurs utilisations. Les composés substitués par IP5 de l'invention sont caractérisés pour avoir des chaînes -O(alkyl)nX, et-O(alkyl)yCy(alkyl)y'-Z dans les positions R1, R2, R4 et R5. L'invention concerne également des procédés, des compositions pharmaceutiques et des formulations, des procédés d'utilisation, des articles manufacturés et des kits pour le traitement de maladies et d'états tels que des maladies et des états pathologiques liés à la cristallisation pathologique.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2024023360A1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | IP5 SUBSTITUTED COMPOUNDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A03%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PERELL%C3%93%20BESTARD,%20Joan&rft.date=2024-02-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024023360A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |